MY AMERICAN SCIENTIST
LOG IN! REGISTER!
SEARCH
 
RSS
Logo
HOME > PAST ISSUE > July-August 2004 > Article Detail

FEATURE ARTICLE

Mad-Cow Disease in Cattle and Human Beings

Bovine spongiform encephalopathy provides a case study in how to manage risks while still learning the facts

Paul Brown

The Nature of the Disease

Both BSE and vCJD belong to a family of diseases known as the transmissible spongiform encephalopathies (TSEs). The oldest known TSE is scrapie, which was first described in sheep in the early 18th century. Natural TSE infections have so far been restricted to sheep and goats (scrapie), and to deer and elk (chronic wasting disease). However, many mammalian species are susceptible to experimental infections by TSE agents, including primates, various ungulates, felines and laboratory rodents. Although the disease has different names in different species, each illness is an expression of the same basic pathological process, and they all share many clinical and biological similarities.

Figure 2. Transmissible spongiform encephalopathies . . .Click to Enlarge Image

The disease agents that cause TSE were recognized as being rather special from the start. Although TSEs behave in many ways like a viral illness, they show some peculiar differences—for example, a long latency period between infection and illness and a correspondingly long duration of illness. The agents also seem to have an astonishing resistance to inactivation and for a very long time could not be linked to any visible structure. For many years the TSE agents were therefore called "slow" or "unconventional" viruses; however, all known biological viruses contain nucleic acids, and 50 years of exhaustive searches for a disease-specific nucleic acid have proved fruitless.

Figure 3. A misfolded protein molecule . . .Click to Enlarge Image

While the search was on for suspicious nucleic acids, another line of research was uncovering the crucial role of a protein—called a prion—that appears to be inseparable from infectivity. Prions are host-encoded proteins, rather than foreign proteins, and more than 30 different mutations in the gene on human chromosome 20 that codes for the prion are associated with inherited forms of TSE. In the infected host, the normal protein (which usually resides on the surfaces of cells, including neurons) is converted into an insoluble form that is resistant to digestion by proteinases. The chain of amino acids that make up the insoluble form is folded differently from the normal protein, and in some ways is similar to the amyloid proteins associated with Alzheimer’s disease. Although scientists have begun to think of TSE as one of a group of "misfolded-protein diseases," it is distinct from other amyloid-based diseases in that it alone is transmissible.

Many scientists believe that the misfolded protein is the primary cause of the disease—that is, the prion itself is the transmissible agent of TSE. Healthy laboratory animals inoculated with tissues from infected animals develop the disease, and the misfolded protein that accumulates in their brains is readily detectable by various immunological methods. But there are still some fundamental questions that have yet to be answered. How, for example, does infection trigger the accumulation of the abnormal prion protein that clutters the diseased brain? In other words, how does the protein replicate? And how can it confer the information required to produce different strains of the infectious agent, both within and between species? One theory suggests that the misfolded protein acts as a seed molecule, a kind of template, that imposes the abnormal conformation on the normal protein. This notion has generated considerable interest in the scientific community, and a number of laboratories are working on the problem. Whatever the final judgment on prions as the sole cause of TSE, it is clear that the protein plays a crucial role in the infectious process and is a valuable marker of infectivity.

Whether it is a lone protein or not, the itinerary of the infectious agent within the body depends on how the infection is initiated. When the agent is experimentally introduced into rodents by inoculation, the abnormal protein replicates in the spleen and the lymph nodes and then travels along the splanchnic nerves (which supply sympathetic innervation in the abdomen) to the spinal cord and then to the brain. If the agent is ingested, it can bypass the spleen and proceed directly from the gut to the brain stem by way of the vagus nerve. Experiments suggest that the optic and olfactory tracts are also potential portals of entry.

The role of circulating blood in naturally occurring TSE remains uncertain. Blood has been shown to be infectious in experimental models of TSE and naturally occurring scrapie infections, and a highly probable case of transmission by means of a "packed" red-cell transfusion from a patient with vCJD was recently reported in Great Britain. During the 1990s, many countries, including the U.S., imposed restrictions on blood donations from persons who lived for three months or more in the United Kingdom between 1980 and 1996, and in March 2004, Great Britain instituted a ban on blood donations from any of its residents who had received a blood transfusion since January 1980.





» Post Comment

 

EMAIL TO A FRIEND :

Of Possible Interest

Sightings: Envisioning Cosmic Collisions

Science Observer: Don't Fence Me Out

Feature Article: The Other Climate Threat: Transportation

Subscribe to American Scientist